News & Events


March 13, 2018

Precision BioLogic, in collaboration with Roche and Genentech, a member of the Roche Group, unveiled data from the study of a new kit for a modified Nijmegen-Bethesda Assay (MNBA) at the Thrombosis & Hemostasis Societies of North America (THSNA) summit in San Diego, California last week. 

March 01, 2018

Heading to San Diego for THSNA March 8-10? If so, we’d love to see you. Drop by and visit us at booth 115.

And, be sure to check out our live poster presentation, Friday at 5:45–6:30 pm.

Poster 143: Performance of a New Kit for a Modified Nijmegen-Bethesda Assay: Comparison of a Chromogenic Versus a Clot-based Factor VIII Inhibitor Assay in Plasma from Persons with Hemophilia A (PwHA)
Ali Sadeghi-Khomami, Marc Boylan, David C. Chen, Joanne I. Adamkewicz


Here’s a list of conferences we’ll be attending this year. If you’re planning on attending any of the same shows, be sure to swing by our booth for a chat because, after all, it’s you we want to see.

08 to 10
San Diego, CA - Visit us at Booth 115
20 to 24
Glasgow, Scotland - Visit us at Booth 17
18 to 21
Dublin, Ireland - Visit us at Booth G1